Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
gart,ik heb er helemaal geen probleem mee,als er morgen een bod word gedaan op soof, boek dan sluiten van soof, dat heb ik vaker getypt hier.
Waarom wordt er 30 miljoen neergezet en geen 25? Gr Arie de Beuker
Arie de Beuker schreef op 14 november 2017 21:32 :
Waarom wordt er 30 miljoen neergezet en geen 25?
Gr
Arie de Beuker
mogge, dat lezen we wel met de update eind januari.
Jij snapt hem Sproet. Gr Arie de Beuker
Faster, Better Decision Making for Products, Programs and Enterprise Portfolios in Latest Sopheon Release Accolade 11.3 intelligently alerts product leaders on variances from established targets and forecasts to increase transparency and support market success Faster, better decision making enabled by Accolade 11.3MINNEAPOLIS—November 16, 2017—Sopheon, the international provider of software, expertise, and best practices for Enterprise Innovation Performance, today released the latest version of its Accolade® Enterprise Innovation Management (EIM) solution. It is projected that 75 percent of the S&P 500 will be replaced in the next ten years.1 This eye-opening fact is to some degree a function of the increased rate of change caused by digital disruption. The external market is often moving faster than the companies in the market themselves. This is particularly challenging for product, program and portfolio owners who are challenged to increase their decision making cadence to align with market changes taking place while their products are still in development. Accolade 11.3 accelerates strategic investment decision making for products, programs, portfolios and projects by delivering relevant, real-time information and insights to the right people, at the right time – sometimes before they know they need it. Daniel Spang, InnoView Manager in the Corporate Innovation department of RENOLIT Group ?said about the latest release: “We are excited with the advanced individualization and increased smart capability in Accolade 11.3. These offer increased focus and value to our project and portfolio management processes.” Shelly Fetzer, VP of Product at Sopheon, added: “With the Accolade 11.3 release we continue to advance the intelligence that Accolade delivers by connecting people to key real-time data within the contexts of corporate strategy and the individual user’s role and responsibilities.” Accolade 11.3 Focuses Decisions and Action on Real-Time, Trusted Data Product and brand managers gain immediate visibility to out-of-bound conditions, permitting them to act – and react – quickly to achieve critical new product performance commitments such as time to market, revenue, return on investment, and product scope. Cross-functional management can now improve the speed and quality of decision making using objective project and product status reporting that is easily standardized and harmonized across portfolios or entire business units. Online decision spaces make for more efficient and effective meetings for both decision makers and knowledge workers, with decision-focused information, collaboration and communications. Accolade 11.3 is available immediately for upgrade, purchase and implementation. All Sopheon Accolade customers who are current on Maintenance and Support program fees are entitled to receive updates to their currently licensed products for this and future release upgrades. New capabilities in Accolade 11.3 are also available to customers with Accolade Express for PPM deployments. Implementation services may be required. 1 Richard N. Foster, co-author of Creative Destruction About Sopheon Sopheon partners with customers to provide complete Enterprise Innovation Management solutions including patented software, expertise, and best practices to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange.
mogge, ze geven elke keer die release gratis aan hun klanten, poen moeten ze vragen nikssss gratis, ik zal die mence een keer aan zn flap oren pakken.
sproetje schreef op 15 november 2017 11:52 :
[...]
mogge, dat lezen we wel met de update eind januari.
Juistem. Het moge duidelijk zijn dat dergelijke zaken geen typefouten mogen en zullen bevatten! Dus we gaan het meemaken. Klaas
Ze zoeken weer iemand voor redelijk grote bedrijven binnen te halen !Sopheon : Sales Executive-Amsterdam share with twitter share with LinkedIn share with facebook share via e-mail 0 11/17/2017 | 07:06pm CET Territory: Companies based in BeNeLux (Netherlands, Belgium and Luxemburg), with a revenue up to 1 billion Euro. Responsibilities and Duties The Sopheon team is seeking a 'hunter' sales executive with a proven track record of closing business with new customers in the territory. This role will be largely focused on medium-sized businesses up to 1 billion Euro of revenue. Accolade is very configurable and will be able to cope with a large variety of use cases. Sopheon also has a dedicated approach with embedded best practices called Accolade Express which will be suitable for part of the territory that is (initially) planning to use the best practices embedded in Accolade Express. Are you the ideal candidate? Can you demonstrate a track record of the following? Business-to-business sales to large complex global firms. Expertise in securing access through your own efforts to upper level executives for compelling sales conversations. Comfort with C-level relationships in companies up to 1 billion Euro revenue. Ability to identify undisclosed customer needs in at least medium sized organizations. Team selling and use of all your companies' resources to aid sales process. Interpreting public information on a prospect account such as annual reports and stock holder information for account qualification and to identify entry message. Understanding strategic selling and the roles of various buying influencers. Developing and maintaining a quality pipeline of potential opportunities. Driving complex enterprise deals for at least medium sized businesses end to end from personal lead generation and qualification, to solution development and presentation, to contract negotiations, to deal closing and to making sure the deal is property transitioned to support teams. Some coaching and help will be available from the Sopheon Amsterdam team. Developing partnerships with relevant players in the Territory, in order to be able to address the local small- and medium-size businesses. Awareness and sensibility to local culture as relevant in each individual country in the Territory. Building compelling business cases to support proposals and identify return on investment, successfully converting opportunities into license sales and consulting engagements. Developing strong relationships with potential clients at SVP, Director and C-levels particularly with prospect R&D, Marketing and Innovation Management functional areas. Managing and reporting opportunities pipeline in Salesforce.com. Adapting to existing team chemistry and supporting an organization to reach its objectives. Experience in selling to vertical markets of consumer packaged goods, industrial manufacturing, chemical, high technology, medical devices, aerospace & defense, automotive. Has an existing network of contacts for shortening the sales cycle, particularly within research and development, innovation, marketing and/or general management. Skills and Expertise: 3-5 years' experience in a consultative sales process with complex 'business centric' enterprise deals with at least medium sized firms. Experience selling entire innovation management and new product development (NPD) lifecycle solutions. Understanding and familiarity of the Stage-Gate product development methodology (preferred). Consistently at or averaging above quota €1.5m. Ability to develop and maintain executive level relationships. Experience selling to the BeNeLux territory with proven track record. Preferably experienced in Brand management and other product development related areas. Willingness and ability to travel as necessary. Native Dutch speaker and Fluent in English. Knowledge of additional languages such as French and/or German are nice to haves. Education and Experience: Degree in Management, Business, Economics, MBA a plus (or equivalent). 3-5 years of experience in direct enterprise software field sales. Recent evidence of achieving targets of €1.5m plus. We seek Sales Leaders with a Passion for: Understanding and diagnosing customer business needs and articulating a solution. Use of social media to gain contact with appropriate executives. Superior communication skills (written, verbal and presentation) Ability to utilize PowerPoint or other media to synthesize and present a compelling business case/rationale. Exceedingly comfortable with C-level interactions. Trinko
middag, ik blijf het een groot gat vinden,van eind augustus tot eind januarie, maarja het is niet anders.
Is er al 3 dagen geen handel?
ik heb gisteren nog een klein beetje gekocht, dus er is wel iets van handel. gezien de vacatureteksten verwacht ik eind januari toch geode berichten en dito koersen :-) gr. OVI
Ik kijk altijd op de beurs.nl en daar zag ik al dagen geen beweging, maar zie dat hij vandaag op 3,70 staat.
Gartje schreef op 22 november 2017 11:59 :
Is er al 3 dagen geen handel?
Nee, er is wel handel met de laatste koop op 370,00www.lse.co.uk/SharePrice.asp?sharepri...
Ik zag het klaas, normaal zie ik de beursbewegingen met volumes op beurs.nl en zo kom ik ook op dit forum, dus er zit weer stijgende lijn in gelukkig.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
910,59
0,00%
EUR/USD
1,0774
+0,03%
FTSE 100
8.433,76
0,00%
Germany40^
18.795,90
+0,12%
Gold spot
2.351,63
-0,39%
NY-Nasdaq Composite
16.340,87
-0,03%
Stijgers
Dalers